Consistent with previous results that miR-375 presents anti-cancer activity through targeting HOXB3 in pancreatic cancer and breast cancer [33, 34], our data indicate that overexpression of miR-375 inhibits cell proliferation and colony formation through inhibiting HOXB3 expression. Here, HOXB3 is linked to breast cancer.